Pharma News
Stay current with the latest pharma news! PharmaLeaders has everything you need to lead!
-
Amgen’s Breakthrough Weight Loss Injection: A Game-Changer in Obesity Treatment
Amgen is on the brink of revolutionizing the weight loss medication market with its groundbreaking product, maridebart cafraglutide (MariTide), currently…
Read More » -
Alert on Counterfeit Ozempic: Risks and FDA Response to Fake Diabetes Medication
Recent reports have highlighted significant health risks associated with counterfeit and compounded versions of Novo Nordisk’s diabetes drug, Ozempic. In…
Read More » -
CES 2024 Brings It Home: Top 10 Anywhere Health Breakthroughs You Won’t Want to Miss
CES 2024 continues to be a hotbed of innovation, especially in the healthcare and in-home care sectors. Here are additional…
Read More » -
JP Morgan Healthcare Conference Update
As the healthcare industry evolves at a breathtaking pace, the JP Morgan Healthcare Conference remains a pivotal event, showcasing groundbreaking…
Read More » -
Amgen Revolutionizes Drug Discovery with NVIDIA’s AI Technology and Human Genome Insights
Amgen, a global leader in biotechnology, is pioneering the use of Generative AI in drug discovery, leveraging one of the…
Read More » -
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect™
So 2024 is starting off with a digital patient experience milestone from industry giant Eli Lilly. As we’ve written about…
Read More » -
Innovating Ophthalmology: A Dialogue with Azura’s CEO
As Azura Ophthalmics strides forward in the field of ophthalmology, we had the opportunity to sit down with Marc Gleeson,…
Read More » -
Court Upholds FTC Decision to Block IQVIA-DeepIntent Merger, Safeguarding Competition in Pharma Programmatic Advertising
In a significant development for the pharmaceutical industry, a U.S. court affirmed the Federal Trade Commission’s decision to halt the…
Read More » -
Pfizer Closes $43 Billion Seagen Deal, Overhauls Commercial Structure Amid Regulatory Clearance
Pfizer, the New York-based pharmaceutical giant, is set to complete its $43 billion acquisition of cancer drugmaker Seagen this Thursday,…
Read More » -
Pfizer discontinues twice daily weight loss pill due to high rates of adverse side effects
Pfizer announced on Friday that it would stop developing the twice-daily version of its experimental weight loss pill. While most common adverse events…
Read More »